Publicaciones (96) Publicaciones de Santiago Vivas Alegre

2024

  1. Assessing mucosal recovery in celiac disease - Time to diagnosis and histological severity as determining factors

    Revista espanola de enfermedades digestivas, Vol. 116, Núm. 7, pp. 356-361

  2. Outcomes of transcatheter aortic valve implantation in gastrointestinal bleeding

    REC: CardioClinics, Vol. 59, Núm. 1, pp. 71-72

2023

  1. Serum anti-tissue transglutaminase IgA and prediction of duodenal villous atrophy in adults with suspected coeliac disease without IgA deficiency (Bi.A.CeD): a multicentre, prospective cohort study

    The Lancet Gastroenterology and Hepatology, Vol. 8, Núm. 11, pp. 1005-1014

2022

  1. Consumption of Tritordeum Bread Reduces Immunogenic Gluten Intake without Altering the Gut Microbiota

    Foods, Vol. 11, Núm. 10

2021

  1. Chromoendoscopy with Indigo Carmine vs Virtual Chromoendoscopy (iSCAN 1) for Neoplasia Screening in Patients with Inflammatory Bowel Disease: A Prospective Randomized Study

    Inflammatory Bowel Diseases, Vol. 27, Núm. 8, pp. 1256-1262

  2. Coeliac disease in elderly patients: Value of coeliac lymphogram for diagnosis

    Nutrients, Vol. 13, Núm. 9

  3. Oral consumption of bread from an RNAi wheat line with strongly silenced gliadins elicits no immunogenic response in a pilot study with celiac disease patients

    Nutrients, Vol. 13, Núm. 12

  4. The Risk of Contracting COVID-19 Is Not Increased in Patients With Celiac Disease

    Clinical Gastroenterology and Hepatology

  5. Tritordeum breads are well tolerated with preference over gluten-free breads in non-celiac wheat-sensitive patients and its consumption induce changes in gut bacteria

    Journal of the Science of Food and Agriculture, Vol. 101, Núm. 8, pp. 3508-3517

2020

  1. Gamma delta+ intraepithelial lymphocytes and coeliac lymphogram in a diagnostic approach to coeliac disease in patients with seronegative villous atrophy

    Alimentary Pharmacology and Therapeutics, Vol. 51, Núm. 7, pp. 699-705

  2. Nuevos biomarcadores en la enfermedad celiaca

    Revista Española de Enfermedades Digestivas, Vol. 112, Núm. 10, pp. 792-796

  3. The human digestive tract is capable of degrading gluten from birth

    International Journal of Molecular Sciences, Vol. 21, Núm. 20, pp. 1-11

2019

  1. Challenges to drug discovery for celiac disease and approaches to overcome them

    Expert Opinion on Drug Discovery, Vol. 14, Núm. 10, pp. 957-968

2018

  1. Duodenal mucosa FOXP3 expression in different etiologies of lymphocytic duodenosis

    Histology and Histopathology, Vol. 33, Núm. 1, pp. 65-71

  2. New coeliac disease treatments and their complications

    Gastroenterologia y Hepatologia

  3. Seguimiento del paciente celíaco: ¿es la recuperación de la mucosa un objetivo del tratamiento?

    Avances en el conocimiento de las patologías relacionadas con el gluten y evolución de los alimentos sin gluten (Sociedad Española de Enfermedad Celíaca (SEEC)), pp. 328-341

  4. The dietary intervention of transgenic low-gliadin wheat bread in patients with non-celiac gluten sensitivity (NCGS) showed no differences with gluten free diet (GFD) but provides better gut microbiota profile

    Nutrients, Vol. 10, Núm. 12

  5. Tritordeum: a novel cereal for food processing with good acceptability and significant reduction in gluten immunogenic peptides in comparison with wheat

    Journal of the Science of Food and Agriculture, Vol. 98, Núm. 6, pp. 2201-2209

2017

  1. Coeliac disease and gastrointestinal symptom screening in adult first-degree relatives

    Journal of Gastroenterology and Hepatology (Australia), Vol. 32, Núm. 12, pp. 1931-1937

  2. Gluten-degrading bacteria are present in the human small intestine of healthy volunteers and celiac patients

    Research in Microbiology, Vol. 168, Núm. 7, pp. 673-684